These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 21516484)
1. DAPK promoter hypermethylation in tissues and body fluids of oral precancer patients. Liu Y; Zhou ZT; He QB; Jiang WW Med Oncol; 2012 Jun; 29(2):729-33. PubMed ID: 21516484 [TBL] [Abstract][Full Text] [Related]
2. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma. Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394 [TBL] [Abstract][Full Text] [Related]
3. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC. Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973 [TBL] [Abstract][Full Text] [Related]
4. Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer. Sun W; Zaboli D; Wang H; Liu Y; Arnaoutakis D; Khan T; Khan Z; Koch WM; Califano JA Clin Cancer Res; 2012 Feb; 18(4):1082-91. PubMed ID: 22228635 [TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma. Hu SL; Kong XY; Cheng ZD; Sun YB; Shen G; Xu WP; Wu L; Xu XC; Jiang XD; Huang DB Tumori; 2010; 96(5):726-33. PubMed ID: 21302620 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas. Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000 [TBL] [Abstract][Full Text] [Related]
7. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer]. Zhang S; Kong WJ Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335 [TBL] [Abstract][Full Text] [Related]
8. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma. Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653 [TBL] [Abstract][Full Text] [Related]
9. [Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women]. Niyazi M; Liu XW; Zhu KC Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):31-4. PubMed ID: 22490852 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC). Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549 [TBL] [Abstract][Full Text] [Related]
11. Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma. Xiaofang L; Kun T; Shaoping Y; Zaiqiu W; Hailong S World J Surg Oncol; 2012 Jan; 10():5. PubMed ID: 22230750 [TBL] [Abstract][Full Text] [Related]
12. Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression. Kuester D; Dar AA; Moskaluk CC; Krueger S; Meyer F; Hartig R; Stolte M; Malfertheiner P; Lippert H; Roessner A; El-Rifai W; Schneider-Stock R Neoplasia; 2007 Mar; 9(3):236-45. PubMed ID: 17401463 [TBL] [Abstract][Full Text] [Related]
14. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Buckingham L; Penfield Faber L; Kim A; Liptay M; Barger C; Basu S; Fidler M; Walters K; Bonomi P; Coon J Int J Cancer; 2010 Apr; 126(7):1630-9. PubMed ID: 19795445 [TBL] [Abstract][Full Text] [Related]
15. [Promoter methylation of DAPK gene in cervical carcinoma]. Zhao XL; Meng ZY; Qiao YH; Zhang HL Ai Zheng; 2008 Sep; 27(9):919-23. PubMed ID: 18799028 [TBL] [Abstract][Full Text] [Related]
16. DNA content and methylation of p16, DAPK and RASSF1A gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients. Laytragoon-Lewin N; Chen F; Castro J; Elmberger G; Rutqvist LE; Lewin F; Turesson I; Lundgren J Anticancer Res; 2010 Nov; 30(11):4643-8. PubMed ID: 21115918 [TBL] [Abstract][Full Text] [Related]
17. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer. Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112 [TBL] [Abstract][Full Text] [Related]
18. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only. De Schutter H; Geeraerts H; Verbeken E; Nuyts S Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529 [TBL] [Abstract][Full Text] [Related]
19. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase. Chen WT; Hung WC; Kang WY; Huang YC; Chai CY Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697 [TBL] [Abstract][Full Text] [Related]